Cite
HARVARD Citation
Tang, H. et al. (2020). Clinical efficacy and safety of novel carbapenem/β-lactamase inhibitor combinations against carbapenem-non-susceptible Gram-negative bacterial infection. Journal of global antimicrobial resistance. pp. 111-112. [Online].